Wird geladen...
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
Selection of cancer patients for treatment with immune checkpoint inhibitors remains a challenge due to tumour heterogeneity and variable biomarker detection. PD-L1 expression in 24 surgical chordoma specimen was determined immunohistochemically with antibodies 28-8 and E1L3N. The ability of patient...
Gespeichert in:
| Veröffentlicht in: | Br J Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889147/ https://ncbi.nlm.nih.gov/pubmed/31666667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0616-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|